65, quai Georges Gorse
Boulogne-Billancourt 92100
France
33 1 58 33 50 00
https://www.ipsen.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - Specialty & Generic
Funcionários Integrais: 5.325
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. David Loew | MD, CEO & Director | 2,22M | N/A | 1967 |
Mr. Aymeric Le Chatelier | Executive VP & CFO | 731,25k | N/A | 1969 |
Dr. Aidan Murphy Ph.D. | Executive VP and Head of Technical Operations | N/A | N/A | 1966 |
Mr. Craig Marks | Vice-President of Investor Relations | N/A | N/A | N/A |
Mr. Francois Garnier | Executive VP of Legal Affairs, General Counsel & Chief Business Ethics Officer | N/A | N/A | 1962 |
Ms. Gwenan White | Executive VP and Head of Communications, Public Affairs & Sustainability | N/A | N/A | N/A |
Mr. Regis Mulot | Executive VP & Chief Human Resources Officer | N/A | N/A | 1966 |
Ms. Dominique Bery | Head of Nordics & Baltics | N/A | N/A | 1971 |
Mr. Bartosz Bednarz D.D.S. | Executive VP and Head of Global Product & Portfolio Strategy | N/A | N/A | N/A |
Mr. Philippe Lopes-Fernandes CBO | Executive VP & Chief Business Officer | N/A | N/A | N/A |
O QualityScore de governança da ISS da Ipsen S.A. a partir de 1 de março de 2024 é 7. As principais pontuações para Auditoria são: 8; Conselho: 7; Direitos de Acionistas: 7; Compensação: 6.